through the Integration of Biosensing and AI
Ultra-Precision Sensing Technology
Model BA200
Designed for non-invasive point-of-care assessment of airway inflammation, this device combines high-sensitivity biosensor technology (0.1 ppb) with full ATS/ERS compliance. It delivers multi-parameter results—FeNO, CaNO, FnNO—in under one minute, while a patented dual-channel design ensures complete protection against cross-contamination.
More
Driven by a passion for innovation and a commitment to excellence, desire to maintain high levels of innovation, knowledge, technical expertise, service.
Committed to providing solutions for respiratory diseases, cardiovascular diseases and metabolic diseases
Become a global provider in comprehensive chronic disease solution for both professional segment and homecare.
When you breathe, your lungs tell a story—one of resistance, reactance, and tiny vibrations deep within your airways. Traditionally, doctors asked patients to “blow hard and fast” into a spirometer. But what if the patie...
Every year on May 31st, the World Health Organization (WHO) and global health partners observe World No Tobacco Day. This annual campaign is designed to raise awareness about the deadly effects of tobacco use, expose the tactics of the to...
EAACI Congress 2026
Please complete the form to contact our team